Martin Becker

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 3

Top Topics

Tyrosine Kinase

Gene Expression

Chronic Myeloid Leukemia

Top Venues

The EMBO journal

Journal of immunology (Baltimore, Md. : 1950)

Molecular cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Ehsan Bahrami, Jan Philipp Schmid, Vindi Jurinovic, Martin Becker, Anna-Katharina Wirth, Romina Ludwig, Sophie Kreissig, Tania Vanessa Duque Angel, Diana Amend, Katharina Hunt, Rupert Öllinger, Roland Rad, Joris Maximillian Frenz, Maria Solovey, Frank Ziemann, Matthias Mann, Binje Vick, Christian Wichmann, Tobias Herold, Ashok Kumar Jayavelu, Irmela Jeremias
Combined proteomics and CRISPR‒Cas9 screens in PDX identify ADAM10 as essential for leukemia in vivo. Molecular cancer 22 (1) (2023)
Xiaocui He, Kathrin Kläsener, Joseena M Iype, Martin Becker, Palash C Maity, Marco Cavallari, Peter J Nielsen, Jianying Yang, Michael Reth
Continuous signaling of CD79b and CD19 is required for the fitness of Burkitt lymphoma B cells. The EMBO journal 37 (11) (2018)
Ella Levit-Zerdoun, Martin Becker, Roland Pohlmeyer, Isabel Wilhelm, Palash Chandra Maity, Klaus Rajewsky, Michael Reth, Elias Hobeika
Survival of Igα-Deficient Mature B Cells Requires BAFF-R Function. Journal of immunology (Baltimore, Md. : 1950) 196 (5) (2016)